In my humble opinion, should Sth Africa trials go very well, VHL should go license this with a big Pharma asap, I dont agree with them "seeking non-dilutive funding for PhaseII in the USA prior to seeking licensing after those trials"... the clock on patent expiry is always ticking and given VHL's meagre funds, they need to give it to the big boys & let them run with it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $47.31M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 3.0¢ | $107.6K | 3.564M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 702000 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 113239 | 2 |
View Market Depth
| Last trade - 15.21pm 04/07/2025 (20 minute delay) ? |
| VHL (ASX) Chart |